ISO 9001 Certified in Valuation Advisory

ISO 9001 Certified in Valuation Advisory

impairment assessment

Valtech Valuation Completes Impairment Testing for Plant and Machinery (Electric Vehicle Related) Assets

Categories: Business Valuation, Financial Reporting IFRS HKFRS|Tags: |

Valuation of Machinery & Equipment under IAS 36 Impairment of Assets Valtech Valuation is pleased to announce the successful completion of an impairment testing engagement on machinery and equipment related to electric vehicle (EV) technology. This project highlights Valtech’s capability in valuing next-generation industrial assets within rapidly evolving sectors, while maintaining strict compliance with

Read More

Impairment Assessment of Property, Plant, and Equipment (PPE): Key Considerations and Valuation Challenges

Categories: Business Valuation, Valtech Insights|Tags: , , |

Explore key considerations and valuation challenges in the impairment assessment of Property, Plant, and Equipment (PPE) for effective financial analysis.

Read More

Valtech Valuation Safeguards Value through Impairment Testing

Categories: Business Valuation, Goodwill Impairment|Tags: , , , |

Valtech transforms complex valuation challenges into strategic outcomes. Explore how our impairment testing for a Hong Kong-based company ensured compliance and preserved value with technical expertise.

Read More

Valtech Valuation Completes Valuation on Environment Hygiene Business

Categories: Business Valuation|Tags: , |

Valtech’s valuation team has recently completed a valuation (impairment assessment) for a listed blue-chip company for its environment hygiene business. We are glad to be a trusted valuation firm for delivering valuation opinion to clients from environmental sustainability industry.

Read More

Biotech Valuation & Healthcare Valuation Service Updates

Categories: Business Valuation, Valtech Insights|Tags: , , , , |

Given the uncertainties associated with valuation of biotech enterprises, valuers can put stronger effort in benchmarking. A solid pool of comparable listed companies and comparable transaction will be highly useful to support valuation assumptions at different clinical trial phase.

Read More
Go to Top